Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.

<h4>Background</h4>Chronic kidney disease (CKD) is an important risk factor for mortality from COVID-19. Remdesivir has been shown to shorten time to recovery in patients with severe COVID-19. However, exclusion of patients with severe kidney function impairment in clinical trials has le...

Full description

Bibliographic Details
Main Authors: Rituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, Ian A Strohbehn, Joshua D Long, James E Dinulos, Destiny Harden, Vinay B Kadiyala, Daiana Moreno, Meghan E Sise
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0279765